MENU
+Compare
SRBT
Stock ticker: OTC
AS OF
Jun 30 closing price
Price
$0.40
Change
+$0.09 (+29.03%)
Capitalization
380.98K

SRBT stock forecast, quote, news & analysis

Shanrong Biotechnology Corp Is a holding company for select biotechnology, health, and wellness operations... Show more

SRBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for SRBT with price predictions
Jul 03, 2025

SRBT's RSI Indicator leaves overbought zone

The 10-day RSI Indicator for SRBT moved out of overbought territory on June 27, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 instances where the indicator moved out of the overbought zone. In of the 18 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 46 cases where SRBT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on June 30, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SRBT as a result. In of 56 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SRBT turned negative on June 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .

The Aroon Indicator for SRBT entered a downward trend on June 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

SRBT moved above its 50-day moving average on June 30, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SRBT crossed bullishly above the 50-day moving average on June 18, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SRBT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (237.949). P/E Ratio (0.000) is within average values for comparable stocks, (160.134). Dividend Yield (0.000) settles around the average of (0.104) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (155.883).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Highlights

Industry description

Financial conglomerates usually encompass a wide range of financial services including (not necessarily limited to) investment banking, insurance, capital raising/underwriting, trading of financial securities, investment advisory services, wealth management of high net-worth individuals, and retail banking. Think Citigroup, American Express Company, ING Group.

Market Cap

The average market capitalization across the Financial Conglomerates Industry is 4.72B. The market cap for tickers in the group ranges from 1 to 590.24B. IMAQU holds the highest valuation in this group at 590.24B. The lowest valued company is MDCE at 1.

High and low price notable news

The average weekly price growth across all stocks in the Financial Conglomerates Industry was -1%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 5%. IHAI experienced the highest price growth at 21%, while JVSAU experienced the biggest fall at -62%.

Volume

The average weekly volume growth across all stocks in the Financial Conglomerates Industry was -12%. For the same stocks of the Industry, the average monthly volume growth was -60% and the average quarterly volume growth was 17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 63
P/E Growth Rating: 73
Price Growth Rating: 59
SMR Rating: 90
Profit Risk Rating: 94
Seasonality Score: 9 (-100 ... +100)
View a ticker or compare two or three
SRBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry FinancialConglomerates

Profile
Fundamentals
Details
Industry
N/A
Address
370 Amapola Avenue
Phone
+1 424 358-1046
Employees
3
Web
http://www.srbtmerger.com